The Involvement of ATP Sensitive Potassium Channel in Migraine Aura and Migraine Pain.
Launched by DANISH HEADACHE CENTER · Sep 29, 2022
Trial Information
Current as of May 14, 2025
Unknown status
Keywords
ClinConnect Summary
This clinical trial is looking into how certain channels in the brain, called ATP-sensitive potassium (KATP) channels, might play a role in migraine headaches and the aura that some people experience before a migraine. Researchers want to find out if opening these channels leads to migraine pain and if it can trigger the changes in the brain that cause aura symptoms, such as visual disturbances.
To participate in this study, you need to be between 18 and 60 years old and have a history of migraines. You're eligible if you weigh between 50 and 100 kg and are generally healthy, without serious medical conditions or other types of headaches. Women who can become pregnant must use effective birth control during the study. If you join, you will help researchers understand more about migraines, and you may undergo some tests, including MRI scans, to gather important information. The trial is currently recruiting participants, so if you’re interested, it could be a great opportunity to contribute to migraine research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Migraine patients
- • 18-60 years.
- • 50-100 kg.
- • Women of childbearing potential must use adequate contraception.
- Exclusion Criteria:
- • A history of serious somatic disease
- • Any other type of headache (except episodic tension-type headache less than once a month) Daily intake of any medication except contraceptives Contraindications for MRI scan.
About Danish Headache Center
The Danish Headache Center is a leading research institution dedicated to advancing the understanding and treatment of headache disorders. As a prominent clinical trial sponsor, the center focuses on innovative therapeutic approaches and comprehensive patient care, aiming to improve the quality of life for individuals suffering from various types of headaches, including migraines and tension-type headaches. With a multidisciplinary team of experts in neurology, psychology, and pain management, the Danish Headache Center is committed to conducting rigorous clinical trials that contribute to evidence-based practices and the development of novel interventions in headache research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, Glostrup, Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials